These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21278927)

  • 1. Prescription Drug Abuse & Diversion: Role of the Pain Clinic.
    Rigg KK; March SJ; Inciardi JA
    J Drug Issues; 2010; 40(3):681-702. PubMed ID: 21278927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of prescription medication diversion among drug dealers.
    Rigg KK; Kurtz SP; Surratt HL
    Drugs (Abingdon Engl); 2012; 19(2):144-155. PubMed ID: 22665955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of prescription drug diversion among drug-involved club- and street-based populations.
    Inciardi JA; Surratt HL; Kurtz SP; Cicero TJ
    Pain Med; 2007 Mar; 8(2):171-83. PubMed ID: 17305688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Women who doctor shop for prescription drugs.
    Worley J; Thomas SP
    West J Nurs Res; 2014 Apr; 36(4):456-74. PubMed ID: 24168912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
    Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
    Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical record-based ascertainment of behaviors suggestive of opioid misuse, diversion, abuse, and/or addiction among individuals showing evidence of doctor/pharmacy shopping.
    Esposito DB; Cepeda MS; Lyons JG; Yin R; Lanes S;
    J Pain Res; 2019; 12():2291-2303. PubMed ID: 31413626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use.
    Rutkow L; Chang HY; Daubresse M; Webster DW; Stuart EA; Alexander GC
    JAMA Intern Med; 2015 Oct; 175(10):1642-9. PubMed ID: 26280092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription drug abuse communication: A qualitative analysis of prescriber and pharmacist perceptions and behaviors.
    Hagemeier NE; Tudiver F; Brewster S; Hagy EJ; Hagaman A; Pack RP
    Res Social Adm Pharm; 2016; 12(6):937-948. PubMed ID: 26806859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased diversion by doctor-shopping for a reformulated extended release oxycodone product (OxyContin).
    Chilcoat HD; Coplan PM; Harikrishnan V; Alexander L
    Drug Alcohol Depend; 2016 Aug; 165():221-8. PubMed ID: 27372220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The "black box" of prescription drug diversion.
    Inciardi JA; Surratt HL; Cicero TJ; Kurtz SP; Martin SS; Parrino MW
    J Addict Dis; 2009 Oct; 28(4):332-47. PubMed ID: 20155603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple Determinants of Specific Modes of Prescription Opioid Diversion.
    Cicero TJ; Kurtz SP; Surratt HL; Ibanez GE; Ellis MS; Levi-Minzi MA; Inciardi JA
    J Drug Issues; 2011; 41(2):283-304. PubMed ID: 22287798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Last State to Grant Nurse Practitioners DEA Licensure: An Education Improvement Initiative on the Florida Prescription Drug Monitoring Program.
    Kellams JR; Maye JP
    J Addict Nurs; 2017; 28(3):135-142. PubMed ID: 28863055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for drug diversion in a pain clinic patient population.
    Walker MJ; Webster LR
    J Opioid Manag; 2012; 8(6):351-62. PubMed ID: 23264313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combating the prescription painkiller epidemic: a national prescription drug reporting program.
    Shepherd J
    Am J Law Med; 2014; 40(1):85-112. PubMed ID: 24844043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of prescription monitoring programs on chronic pain management.
    Wang J; Christo PJ
    Pain Physician; 2009; 12(3):507-15. PubMed ID: 19461820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Law enforcement-derived data on gabapentin diversion and misuse, 2002-2015: diversion rates and qualitative research findings.
    Buttram ME; Kurtz SP; Dart RC; Margolin ZR
    Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1083-1086. PubMed ID: 28493425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I--evidence assessment.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S1-65. PubMed ID: 22786448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sources of prescription opioids among diagnosed opioid abusers.
    Shei A; Rice JB; Kirson NY; Bodnar K; Birnbaum HG; Holly P; Ben-Joseph R
    Curr Med Res Opin; 2015 Apr; 31(4):779-84. PubMed ID: 25661018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).
    Cicero TJ; Dart RC; Inciardi JA; Woody GE; Schnoll S; Muñoz A
    Pain Med; 2007 Mar; 8(2):157-70. PubMed ID: 17305687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.